[3] [5] Never discontinue or adjust your tirzepatide dose without medical guidance
Safe Ways to Discontinue GLP-1 Therapy Planning and communication with your healthcare team are essential components of safely discontinuing GLP-1 receptor agonist therapy
Dull and uneven complexion
Lawyers are pursuing Ozempic, Wegovy and Mounjaro lawsuits over serious side effects, including stomach paralysis, other gastrointestinal injuries and NAION, a rare optic nerve injury linked to sudden and potentially permanent vision loss
GLP-1 medications work by slowing gastric emptying and increasing insulin secretion, which can influence blood glucose levels, kidney function markers, and electrolyte balance
A 2025 mechanistic review published in The Journal of Clinical Endocrinology and Metabolism showed that tirzepatide, which activates the GIP receptor, showed less BMD loss than expected for the weight loss achieved